Trimethoprim / sulfamethoxazole in the treatment of gynecological infections

• Autores: Valdivia Ponce, Eduardo, García La Madrid, Martín
• Formato: artículo
• Fecha de Publicación: 2015
• Institución: Sociedad Peruana de Obstetricia y Ginecología
• Repositorio: Revista Peruana de Ginecología y Obstetricia
• Lenguaje: español
• OAI Identifier: oai:ojs.pkp.sfu.ca:article/753
• Enlace del recurso: http://51.222.106.123/index.php/RPGO/article/view/97-102
• Nivel de acceso: acceso abierto

We conducted a study with 80 patients ginecópatas, mortadores of infection problems. Of these, 60 were treated with a new drug trimethoprim + sulfamethoxazole association and comparatively 10 patients with ampicillin and tetracycline 10 others. In the 60 patients studied with trimethoprim-sulfamethoxazole (TMP / SMX) association is summarized as follows: The finding was between 4 and 58 years old. The group of women aged 20-40 years accounted for 54% of gynecological infections. 44.4% of infections were caused by Escherichia coli, Staphylococcus aureus coagulase corresponding to 24% positive infections. The E. coli / staphylococcus aureus association was found with some frequency. Vaginitis and vulvovaginitis were prevailing clinical infections (59%). Except for a few cases, particularly mixed infections, the standard treatment for 7 days with the association trimethoprim + sulfamethoxazole, they produced satisfactory results with clinical and bacteriological cure nearly 100%.